Cite
Co-targeting BCL-X L and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice.
MLA
Khan, Sajid, et al. “Co-Targeting BCL-X L and MCL-1 with DT2216 and AZD8055 Synergistically Inhibit Small-Cell Lung Cancer Growth without Causing on-Target Toxicities in Mice.” Cell Death Discovery, vol. 9, no. 1, Jan. 2023, p. 1. EBSCOhost, https://doi.org/10.1038/s41420-022-01296-8.
APA
Khan, S., Kellish, P., Connis, N., Thummuri, D., Wiegand, J., Zhang, P., Zhang, X., Budamagunta, V., Hua, N., Yang, Y., De, U., Jin, L., Zhang, W., Zheng, G., Hromas, R., Hann, C., Zajac-Kaye, M., Kaye, F. J., & Zhou, D. (2023). Co-targeting BCL-X L and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice. Cell Death Discovery, 9(1), 1. https://doi.org/10.1038/s41420-022-01296-8
Chicago
Khan, Sajid, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, et al. 2023. “Co-Targeting BCL-X L and MCL-1 with DT2216 and AZD8055 Synergistically Inhibit Small-Cell Lung Cancer Growth without Causing on-Target Toxicities in Mice.” Cell Death Discovery 9 (1): 1. doi:10.1038/s41420-022-01296-8.